Alan L. Epstein

Alan L. Epstein is a Professor in the Department of Pharmacology and Pharmaceutical Sciences at the Keck School of Medicine, University of Southern California. With over 30 years of experience, he specializes in developing monoclonal antibodies and reagents for cancer treatment, resulting in 25 patents and over 150 publications.

His educational background includes:

• Bachelor's degree in biology from Wesleyan University
• MD and PhD from Stanford University School of Medicine (Medical Scientist Training Program)

Prior to USC, he began his academic career in the Department of Medicine, Division of Medical Oncology at Northwestern University School of Medicine. His research focuses on:

• TNT antibodies for cancer imaging and therapy
• Lym-1 antibody for lymphoma treatment
• Vasopermeability enhancing antibodies to improve tumor drug uptake
• LN panel of diagnostic antibodies
• Novel fusion proteins for immunotherapy

Dr. Epstein has consulted extensively for biotechnology companies and is recognized as an accomplished speaker in cancer therapeutics.